Matinas BioPharma Holdings Deal Termination
Matinas BioPharma Holdings, Inc. has terminated its agreement with a former financial advisor, which previously entitled the advisor to up to $4.0 million in cash and stock for business combinations. In connection with the termination, the company paid the advisor $562,500 in cash and exchanged mutual releases. This action removes potential future success-fee obligations related to strategic transactions.